Clinical Trials

53 enrolled 17 charts

Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

NCT03314740 2025-01-10

BAROCCO

123 enrolled 14 charts

Ovarian Neoplasms

NCT00795340 2023-08-22

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 3 Completed

306 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01062425 2022-07-26

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

261 enrolled 10 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02889900 2022-03-08

CONCERTO

62 enrolled 15 charts

Ovarian Neoplasms

NCT01208051 2021-07-15

Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer

Phase 1/2 Completed

127 enrolled 18 charts

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT01132820 2019-08-08

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

53 enrolled 11 charts

Endometrial Adenocarcinoma

NCT00436956 2018-10-09

AZD2171 to Treat Prostate Cancer

59 enrolled 12 charts

Prostatic Neoplasms

NCT00278343 2018-08-29

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

74 enrolled 11 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00243061 2018-08-27

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

24 enrolled 12 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT01260688 2018-08-08

Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel

22 enrolled 23 charts

Prostatic Neoplasms

NCT00410904 2018-04-13

AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer

60 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00243074 2018-01-23

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Other solid neoplasmThoracic

54 enrolled 12 charts

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00384176 2017-04-14

HORIZON III

Phase 2/3 Completed

1,814 enrolled 13 charts

Colorectal Neoplasms

NCT00326599 2017-03-21

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

101 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00475150 2017-02-15

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Other hematologic neoplasm

39 enrolled 9 charts

Congenital Abnormalities, Leukemia, Myeloid, Acute

NCT00423332 2017-02-02

Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma

105 enrolled 12 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms

NCT00399035 2016-12-28

HORIZON II

Phase 3 Completed

1,254 enrolled 14 charts

Colorectal Neoplasms

NCT00777153 2016-12-28

REGAL

Phase 3 Completed

423 enrolled 13 charts

CNS

Glioblastoma, Neoplasms

NCT00454805 2016-08-03

AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

75 enrolled 11 charts

Breast

Advanced Breast Cancer

NCT00227760 2016-02-29

Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery

44 enrolled 8 charts

Carcinoma, Renal Cell

NCT00244881 2015-12-07

A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)

26 enrolled 9 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00275028 2015-11-09

AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

47 enrolled 15 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00245063 2014-10-02

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

25 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00494221 2014-03-27

A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

Phase 1/2 Completed

172 enrolled 12 charts

Neoplasm Metastasis, Colorectal Neoplasms

NCT00243347 2013-10-17

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

Phase 1 Completed

19 enrolled 7 charts

Head & NeckThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT00306891 2012-11-01

Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

60 enrolled 13 charts

Tumor-Agnostic

Neoplasms

NCT00278889 2012-10-24

HORIZON I

215 enrolled 14 charts

Colorectal Neoplasms

NCT00385203 2012-07-16

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).